March 30, 2022 -- Biodiagnostic device company NanoHarmonics has acquired Avagen Pharma, a global distributor of a product that utilizes an advanced drug delivery system to treat premature ejaculation.
For NanoHarmonics, the deal furthers its goal of integrating drug delivery systems, according to the vendor. Its current pipeline includes pain medications and drugs for malaria, tuberculosis, and other infectious diseases, including COVID-19.
Terms of the acquisition were not disclosed.
Copyright © 2022 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
